MedTrace Logo

High Flow Nasal Cannula Versus High Velocity Nasal Insufflation in Covid-19

NCT05216640 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-01-31

No results posted yet for this study

Summary

To compare the outcomes of HFNC and HVNI in COVID-19 patients with acute respiratory failure as regard need for mechanical ventilation, changes of arterial blood gases (ABG) parameters, duration of ventilatory support and delay between admission and intubation

Conditions

Interventions

DEVICE

High Flow Oxygen Therapy

• The patient will be allocated into 2 groups, patients who will require ventilatory support via HFNC and those who will require HVNI

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Maha k Ghanem, MD · Assuit university, Egypt

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-03-31
Completion
2023-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05216640 on ClinicalTrials.gov